For VCs
Screen everything. Go deep selectively.
Put an expert-validated read behind the deals you've decided to go deep on, then extend the same evidence base as far as the thesis demands.
Typical use - pipeline triage, IC prep, portfolio monitoring
Agentic screening reads a company across the domains that decide the deal - tech, commercial, financial, legal and people - from 50+ verified sources, and hands you an evidence-backed verdict where every claim traces to a dated source. The depth of a diligence team, held to the same standard, in hours.
Assess your whole deal pipeline. Your first one is on us - no company access needed.
Domains Covered
One diligence workspace
or watch how a screening runs - 1 min
Why due diligence still hurts
It's slow, it's split across a handful of advisors, and it lands too late to change the deal. Sellers rebuild a data room from memory. Buyers wait on a verdict that should already be theirs. Both sides pay six figures for a one-time snapshot that's stale before signature.
By the time the report lands, the price is set and the process has momentum. Findings become footnotes instead of leverage.
Commercial, tech, legal, people and financial each come back in their own template. Nobody owns the contradictions between them.
Diligence stops the day it's delivered. Nothing tracks whether the company got better or worse through the hold.
The solution
Start at the shallow end on everything you look at, and go deeper only where the deal earns it. Each step inherits the evidence from the one before it - nothing is re-gathered, nothing is lost.
An expert-grade read on any company, before you ask them for anything.
The same screen, with a senior expert underwriting every conclusion.
Company evidence, system access and expert calls on the questions that decide the deal.
Every domain, through to signing - with a value-creation view on the other side.
The platform
One investment record underneath - Ask Lab08, Workbench, Evidence, Reports and MCP all read from it.
How it works
One evidence base behind every domain. Agents gather and cross-check, our own DD experts underwrite what matters, and you choose how much human sign-off sits on top.
Public sources, documents, meetings, technical systems and deterministic tools. Nothing beyond what you choose to share.
Material signals become structured, dated evidence. The source stays attached to the claim.
Evidence is analysed into observations, risks and open questions - then validated by our DD analysts.
One IC-ready assessment: structured, comparable, evidence-linked. Approve, reject or add evidence yourself.
Already trusted by deal teams at
From the deal teams using it
Customer
In our work together on tech investments like Lenus eHealth, Keepit and P-Secure, Lab08 has proven to be a trusted tech due diligence partner. What sets them apart is their ability to translate complex findings into strategic insights that support real decision-making. That's a rare and highly valuable capability in this space.
Jacob Bratting Managing Director & Partner, EIFO Customer
Lab08's platform provides valuable insights, streamlining our analysis and empowering us to make data-driven investment decisions. It's a powerful due diligence and deal flow management tool designed for next-generation funds like ours.
Andreas Green Rasmussen GP, Ugly Duckling Ventures Customer
We've worked with Lab08 on the majority of our tech investments over the past years, and they continue to be a highly valued partner. They bring strong technical insight, and they tailor their approach to fit the nature and stage of each deal. Their ability to adapt while consistently delivering decision-ready insights is a real differentiator.
Magnus Stagsted Partner, People Ventures Who's it for
VCs, PE teams, analysts and partners work from the same evidence-linked record - each at the depth their decision needs.
For VCs
Put an expert-validated read behind the deals you've decided to go deep on, then extend the same evidence base as far as the thesis demands.
Typical use - pipeline triage, IC prep, portfolio monitoring
For PE & growth
Move from the agentic screening to full, expert-led diligence - and keep the record alive through the hold and into exit.
Typical use - control deals, buy-and-build, exit readiness
Get to the material questions faster.
Start with structured evidence instead of assembling the picture manually.
See the investment implications without losing access to the underlying evidence.
Move from headline finding to source when needed.
Not a generic AI report. A diligence system built around the way investment decisions are actually made.
Every tier reads your own fund systems. You're choosing how deep you go, how much company access you give, and how much expert time you want.
A full deal analysed in a few hours - across far more sources than a general-purpose AI can reach, and far deeper.
Technology-led, your experts in the loop
1 hour
€500
per company - all domains in one screen. Your first one is on us.
You get
The same screen, with a senior expert's eye on every conclusion
Technology-led and vetted by an expert
1 day
€5,000
per company - all domains, expert-validated
Plus
Full VC scope, or PE before the NBO
Expert sign-off
1 week+
From €10,000
per domain, scoped per deal
Plus
Everything, for PE and M&A processes
Expert sign-off
1 month
From €50,000
scoped per domain
Plus
Every company in your pipeline, screened.
Your first one is on us.
Public sources only, no company access required. If the read earns your trust, go deeper. Start with a screening, talk to us about a due diligence.
Share a company of interest. Lab08 will collect all available public signals to give you a comprehensive report and help you decide on the right next step.
This assessment is private to your Lab08 workspace. By continuing, you agree to the Privacy Policy.
Already using Lab08? Sign in
We confirm your domain and open your Lab08 workspace.
Agents read the public signals on the company you named.
Once your Lab08 workspace is ready, you’ll receive an email with login details. Sign in to review the report for your selected company.
Cookies
We would like to use analytics cookies to understand how the site is used. They are off unless you turn them on, and the site works either way. See our privacy policy.